Replies to post #209614 on Amarin Corp Plc (AMRN)

[marzan]

when do you and mellow think the market will assign the right price that you both think? I think by the time we are done with the Adcom vote. what is the right price? say for analysis like JT says 1/3rd adults meaning 70M Americans would qualify for V, say 10% take it which is 7M that would correspond to $15B revenue in a year minimum if you sell a year scripts for ~2k per person just U.S. alone. So, if the Adcom votes for this population on the label, pps can rocket to 3 to 12 times of the current which is $45 to $150 a share not talking about a b/o value which could be a minimum double which then could range $90-$300 a share. I invite stalwarts science guru JL et al to view this future value and continue to lead us encouraging us the ardent longs and the weak longs to stay put thru to enjoy the humongous treasure we got.

[rosemountbomber]

Yes Alm2 it was an excellent post by Mellowmoods and glad he took the time to summarize all of that. I liked you post as well and one line of yours that struck a chord with me was:

"Amarin has to GIA unless there is BO-such is not an easy course -many obstacles and costs to overcome JT will not get everything right but........"

Just the other day I read a post by a highly thought of poster who used two words in his post:

"incredibly tiring". Well he was mostly referring to the BS with the FDA and some of JT's actions throughout this process that we are going through. But this is something we will have to learn to live with going down the GIA path. And, of course as you mention later in your post, all these things gang up on our patience and some here will be scared or "tired" out of their shares.

All of this to say that although GIA would ultimately lead to greater gains, it will be an arduous process and will feel incredibly tiring to some. After FDA approval there will still be much work to be done. Selling docs, getting the insurance companies to lower their tiers, making sure not to waste money foolishly and further delay profitability, etc. The question of GIA or BO is out of our hands and because as you and Mellowmoods state, we have an astonishing drug on our hands and so no matter which path the company follows we just have to be patient.